-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk: DeneciMIG showed good tolerability after switching from ecurizumab.

Zhitongcaijing·09/17/2026 11:09:10
Listen to the news
Novo Nordisk: DeneciMIG showed good tolerability after switching from ecurizumab.